ACHC Insider Trading
Acadia Healthcare Company, Inc. | Services-Specialty Outpatient Facilities, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Acadia Healthcare Company, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Specialty Outpatient Facilities, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 01:30 | 2024-03-05 | Miquelon Wade D | Director | SELL | $85.39 | 2,203 | $188,114 | 46,074 | -4.6% |
| 2024-03-07 01:28 | 2024-03-04 | Gregg Vicky B | Director | SELL | $85.56 | 2,500 | $213,900 | 26,851 | -8.5% |
| 2023-12-15 05:14 | 2023-12-12 | OSTEEN DEBRA K | Director | SELL | $77.40 | 43,000 | $3,328,290 | 675,833 | -6.0% |
| 2023-11-17 01:01 | 2023-11-14 | Hollinsworth John S. | Officer - EVP of Operations | SELL | $74.01 | 92,500 | $6,846,304 | 84,630 | -52.2% |
| 2023-11-14 01:42 | 2023-11-08 | Hollinsworth John S. | Officer - EVP of Operations | SELL | $73.58 | 32,500 | $2,391,249 | 177,130 | -15.5% |
| 2023-11-14 01:33 | 2023-11-08 | OSTEEN DEBRA K | Director | SELL | $74.21 | 15,000 | $1,113,150 | 718,833 | -2.0% |
| 2022-09-10 00:05 | 2022-09-07 | GRIECO WILLIAM | Director | SELL | $82.54 | 5,000 | $412,700 | 73,811 | -6.3% |
| 2022-08-09 01:54 | 2022-08-04 | Hollinsworth John S. | Officer - EVP of Operations | SELL | $80.68 | 10,780 | $869,730 | 80,559 | -11.8% |
| 2022-08-09 01:53 | 2022-08-04 | Duckworth David M. | Officer - Chief Financial Officer | SELL | $80.63 | 26,921 | $2,170,678 | 99,263 | -21.3% |
| 2022-08-09 01:52 | 2022-08-04 | Howard Christopher L | Officer - EVP, GC and Secretary | OPT+S | $81.60 | 20,657 | $1,685,706 | 149,147 | 0.0% |
| 2022-08-03 00:01 | 2022-07-29 | Petrie William M | Director | SELL | $83.42 | 6,000 | $500,520 | 31,769 | -15.9% |
| 2021-06-17 00:05 | 2021-06-14 | WAUD REEVE B | Director | SELL | $66.47 | 55,030 | $3,657,844 | 506,844 | -9.8% |
| 2021-06-17 00:05 | 2021-06-14 | Hollinsworth John S. | Officer - EVP of Operations | SELL | $66.31 | 5,000 | $331,550 | 56,275 | -8.2% |
| 2021-03-17 00:10 | 2021-03-12 | GRIECO WILLIAM | Director | SELL | $59.84 | 4,000 | $239,340 | 73,958 | -5.1% |
| 2021-03-16 01:27 | 2021-03-12 | WAUD REEVE B | Director | SELL | $59.12 | 109,443 | $6,470,358 | 561,874 | -16.3% |
| 2021-03-16 00:06 | 2021-03-11 | Duckworth David M. | Officer - Chief Financial Officer | OPT+S | $58.04 | 18,780 | $1,089,991 | 71,773 | 0.0% |
| 2021-03-16 00:01 | 2021-03-11 | Howard Christopher L | Officer - EVP, GC and Secretary | OPT+S | $58.09 | 33,228 | $1,930,215 | 95,008 | 0.0% |
| 2020-06-13 02:50 | 2020-06-12 | WAUD REEVE B | Director | SELL | $25.87 | 122,311 | $3,164,418 | 671,317 | -15.4% |
| 2019-09-09 13:07 | 2019-09-05 | OSTEEN DEBRA K | Director, Officer - Chief Executive Officer | BUY | $26.53 | 20,000 | $530,660 | 117,178 | +20.6% |
| 2018-11-03 01:36 | 2018-11-01 | WAUD REEVE B | Director | SELL | $45.00 | 41,865 | $1,883,925 | 793,628 | -5.0% |
| 2018-07-31 04:52 | 2018-07-26 | WAUD REEVE B | Director | SELL | $45.00 | 8,135 | $366,075 | 835,493 | -1.0% |
| 2018-03-17 00:39 | 2018-03-14 | GOLDBERG RANDALL P | Officer - VP of Business Development | SELL | $41.47 | 400 | $16,589 | 5,357 | -6.9% |
| 2018-03-16 00:27 | 2018-03-15 | WAUD REEVE B | Director | SELL | $42.03 | 7,698 | $323,547 | 843,628 | -0.9% |
| 2018-03-15 01:01 | 2018-03-12 | WAUD REEVE B | Director | SELL | $42.02 | 42,302 | $1,777,640 | 851,326 | -4.7% |
| 2018-03-07 04:32 | 2018-03-02 | WAUD REEVE B | Director | SELL | $39.02 | 200,000 | $7,804,340 | 893,628 | -18.3% |
| 2018-03-03 01:02 | 2018-03-01 | GOLDBERG RANDALL P | Officer - VP of Business Development | SELL | $38.47 | 960 | $36,927 | 5,982 | -13.8% |
| 2017-12-19 01:32 | 2017-12-15 | WAUD REEVE B | Director | SELL | $31.80 | 100,000 | $3,179,700 | 1,097,606 | -8.3% |
| 2017-08-25 00:44 | 2017-08-22 | Gordon Christopher R | Director | SELL | $50.69 | 998,438 | $50,610,822 | 0 | -100.0% |
| 2017-08-23 01:40 | 2017-08-22 | WAUD REEVE B | Director | SELL | $50.69 | 984,075 | $49,882,762 | 1,197,606 | -45.1% |
| 2017-08-23 01:13 | 2017-08-22 | JACOBS JOEY A | Director, Officer - Chief Executive Officer | SELL | $50.69 | 500,000 | $25,345,000 | 267,649 | -65.1% |
| 2017-08-23 01:11 | 2017-08-22 | Fincher Ronald Morgan | Officer - Chief Operating Officer | SELL | $50.69 | 80,000 | $4,055,200 | 11,135 | -87.8% |
| 2017-08-23 01:07 | 2017-08-22 | Howard Christopher L | Officer - EVP, GC and Secretary | SELL | $50.69 | 53,713 | $2,722,712 | 147,286 | -26.7% |
| 2017-08-23 01:05 | 2017-08-22 | TURNER BRENT | Officer - President | SELL | $50.69 | 206,252 | $10,454,914 | 0 | -100.0% |
| 2017-08-15 02:01 | 2017-08-11 | GRIECO WILLIAM | Director | SELL | $51.71 | 2,000 | $103,420 | 44,013 | -4.3% |
| 2017-08-05 00:01 | 2017-08-03 | Howard Christopher L | Officer - EVP, GC and Secretary | SELL | $52.47 | 16,762 | $879,559 | 200,999 | -7.7% |
| 2017-08-03 01:01 | 2017-07-31 | Schwieger Scott | Officer - Chief Compliance Officer | OPT+S | $52.85 | 2,891 | $152,791 | 6,950 | 0.0% |
| 2017-08-02 23:06 | 2017-07-31 | Gordon Christopher R | Director | SELL | $51.65 | 2,453,764 | $126,736,911 | 998,438 | -71.1% |
| 2017-08-02 01:14 | 2017-07-28 | WAUD REEVE B | Director | SELL | $51.72 | 1,240,000 | $64,127,716 | 2,181,681 | -36.2% |
| 2017-07-07 00:53 | 2017-07-05 | WAUD REEVE B | Director | SELL | $50.04 | 50,000 | $2,502,150 | 3,421,681 | -1.4% |
| 2017-06-23 23:10 | 2017-06-22 | WAUD REEVE B | Director | SELL | $47.51 | 50,000 | $2,375,600 | 3,471,681 | -1.4% |
| 2017-06-20 01:00 | 2017-06-16 | GRIECO WILLIAM | Director | SELL | $45.42 | 2,000 | $90,843 | 46,013 | -4.2% |
| 2017-06-15 23:14 | 2017-06-14 | WAUD REEVE B | Director | SELL | $45.53 | 724,694 | $32,995,318 | 3,521,681 | -17.1% |
| 2017-06-13 13:06 | 2017-06-09 | WAUD REEVE B | Director | SELL | $45.09 | 50,000 | $2,254,350 | 4,246,375 | -1.2% |
| 2017-05-06 00:01 | 2017-05-04 | GOLDBERG RANDALL P | Officer - VP of Business Development | OPT+S | $45.18 | 4,925 | $222,512 | 5,682 | 0.0% |
| 2017-05-04 00:13 | 2017-05-01 | Fincher Ronald Morgan | Officer - Chief Operating Officer | OPT+S | $44.43 | 86,483 | $3,842,448 | 41,135 | 0.0% |
| 2017-03-17 23:48 | 2017-03-15 | WAUD REEVE B | Director | SELL | $41.06 | 3,024,891 | $124,202,024 | 4,555 | -99.8% |
| 2017-03-15 01:01 | 2017-03-10 | GRIECO WILLIAM | Director | SELL | $42.56 | 1,000 | $42,560 | 44,261 | -2.2% |
| 2017-03-10 02:00 | 2017-03-07 | Schwieger Scott | Officer - Chief Compliance Officer | SELL | $43.67 | 1,012 | $44,194 | 5,800 | -14.9% |
| 2017-03-10 02:00 | 2017-03-08 | GOLDBERG RANDALL P | Officer - VP of Business Development | SELL | $43.55 | 914 | $39,802 | 7,376 | -11.0% |
| 2017-03-07 02:00 | 2017-03-02 | GRIECO WILLIAM | Director | SELL | $44.64 | 1,000 | $44,640 | 45,261 | -2.2% |
How to Interpret $ACHC Trades
Not every insider transaction in Acadia Healthcare Company, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ACHC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ACHC
Insider activity data for Acadia Healthcare Company, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ACHC, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.